Drug application
SODIUM IODIDE I 131 (SODIUM IODIDE I-131)
Drugs@FDA NDA 016515 · CURIUM
Key facts
| Drug name | SODIUM IODIDE I 131 |
|---|---|
| Active ingredients | SODIUM IODIDE I-131 |
| Application type | NDA |
| Application number | 016515 |
| Company | CURIUM |
| Dosage forms | SOLUTION, ORAL |
| Strength | 3.5-150mCi/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Aug 18, 1971 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: